Company / Assets per Share
Insight Molecular Diagnostics Inc. Assets per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$1.48
FY2025
5-year range
$1.09 / $12.62
FY2021-FY2025
Trend
-65.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Assets per Share has fluctuated over the past 6 years, ranging from $0.97 in FY2020 to $12.62 in FY2023.
Based on SEC 10-K filings.
1.48 in FY2025 with a 5-year CAGR of +8.7%.
Declined from $12.62 to $1.48 over the past 2 years.
Assets per Share over time
Growth rates
- 3-Year CAGR
- +10.8%
- 5-Year CAGR
- +8.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, assets per share decreased 65.2% year-over-year.
- Peak assets per share was recorded in FY2023.
- Lowest assets per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -7.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.48 | -65.2% |
| FY2024 | $4.25 | -66.4% |
| FY2023 | $12.62 | +1063.3% |
| FY2022 | $1.09 | -53.0% |
| FY2021 | $2.31 | +137.6% |
| FY2020 | $0.97 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026